Assembling OX40 aptamers on a molecular scaffold to create a receptor-activating aptamer.
about
Aptamers: A Feasible Technology in Cancer ImmunotherapyAptamers: A promising chemical antibody for cancer therapyNucleic Acid aptamers: new methods for selection, stabilization, and application in biomedical scienceAptamers: A New Technological Platform in Cancer ImmunotherapyMultivalent Aptamers: Versatile Tools for Diagnostic and Therapeutic ApplicationsManipulating the in vivo immune response by targeted gene knockdownAptamer-targeted cell-specific RNA interferenceSelection of Nucleic Acid Aptamers Targeting Tumor Cell-Surface Protein BiomarkersAptamer-targeted antigen delivery.Control of immunity by the TNFR-related molecule OX40 (CD134)Nucleotide bias observed with a short SELEX RNA aptamer libraryAgonistic CD200R1 DNA Aptamers Are Potent Immunosuppressants That Prolong Allogeneic Skin Graft SurvivalA multivalent DNA aptamer specific for the B-cell receptor on human lymphoma and leukemiaSmall-molecule modulators of the OX40-OX40 ligand co-stimulatory protein-protein interactionThe significance of OX40 and OX40L to T-cell biology and immune disease.Aptamer technology for tracking cells' status & function.Microfluidic chip system for the selection and enrichment of cell binding aptamersDNA Aptamer Assembly as a Vascular Endothelial Growth Factor Receptor AgonistAptamers for Targeted Drug DeliveryAgonistic aptamer to the insulin receptor leads to biased signaling and functional selectivity through allosteric modulationTargeting Two Coagulation Cascade Proteases with a Bivalent Aptamer Yields a Potent and Antidote-Controllable Anticoagulant.Identification and characterization of an agonistic aptamer against the T cell costimulatory receptor, OX40.Identification of TIM3 2'-fluoro oligonucleotide aptamer by HT-SELEX for cancer immunotherapy.CD28 aptamers as powerful immune response modulatorsMRP1-CD28 bi-specific oligonucleotide aptamers: target costimulation to drug-resistant melanoma cancer stem cellsThe role of TNF superfamily members in T-cell function and diseases.The chemical biology of aptamers.Aptamers and aptamer targeted delivery.Nucleic acid based molecular devices.Intracellular delivery of RNA-based therapeutics using aptamers.Aptamers as targeted therapeutics: current potential and challenges.Cell-specific aptamers as emerging therapeutics.Nucleic acid aptamers in cancer research, diagnosis and therapy.Stabilized Interleukin-6 receptor binding RNA aptamers.Aptamer-mediated delivery of splice-switching oligonucleotides to the nuclei of cancer cells.Interleukin-6 receptor specific RNA aptamers for cargo delivery into target cells.Targeting 4-1BB costimulation to disseminated tumor lesions with bi-specific oligonucleotide aptamers.Bi-specific aptamers mediating tumor cell lysis.OX40 Agonists and Combination Immunotherapy: Putting the Pedal to the Metal.Composite RNA aptamers as functional mimics of proteins.
P2860
Q26740303-5E6113D2-2E33-4BEB-9BFE-9672613D3BF1Q26766832-B8D996DE-748C-4C25-985A-B65BA3BF6EBBQ26995510-A62617DF-7147-4CCE-8C0C-036766D27592Q28068981-DF0882FC-2E7A-417C-9A5F-5C825F50CEC2Q28073119-782CDEF3-AA91-4C73-A796-C868B7719137Q28083494-F7EE0121-C098-4C4B-B7EF-49A56BC2F13CQ33717239-3F9F2B32-DB40-4349-9107-61AE1B0F6F6AQ33832781-FAA0479E-E4DB-4D75-80ED-BC064D6D7139Q33870736-C9E23B99-263E-4E99-A25E-716FBE4EDF01Q33899607-5C59166E-570C-4229-9EA9-0DBF43709826Q33972934-8645F3C4-78A7-42D7-8179-E9A2F3E7FD25Q34459418-78A293ED-2D27-4A84-8774-B0E7532E84EDQ34723932-AA8E6F99-6D19-40AB-A809-F9960C506BA1Q34954124-CE7908A3-71EE-46A6-9976-351B7E395172Q34979946-03051D1D-CD42-4885-8220-CB0DB9EBBF99Q35673895-5B3F0737-07E0-43D3-81A6-CD91F245B7ABQ35693283-44778886-8404-472B-A09D-AB93303DDF05Q36078454-5FE3ECA4-C0CB-4BF7-B362-A1C4DF9DC123Q36155891-C03AC798-1757-4B3E-BED3-83FA712BB2DFQ36299173-B058C7C0-E19C-407A-80E9-FEF8B63C9CB0Q36580126-31C8C62B-4AF3-45C8-AC57-987EF8396A3CQ36603032-92A7B026-5479-47A0-86DE-5448B9D3F876Q36782499-957A7575-0DE6-480E-A785-4CA8A93FF67CQ36968197-4A71234A-1A23-4222-A4B4-E65ADEE2E7A8Q37268962-24A35566-ED8A-4544-8163-29282D989359Q37332068-DFC7A12B-5607-4397-961E-2D009397D329Q37423243-47C1F631-35DC-4E1A-9ED0-AB0DBA9CF3C4Q37490756-60F1F06E-2A62-4CDF-8485-2DB2BFC84A89Q37857036-91C4BE82-2BCF-4958-B980-2F8B1936BC5CQ37885186-E7FFD6B8-7D57-4957-BF6A-5045593E0FEFQ38290290-4BB50F64-5891-4B61-B57F-B05F86C3853BQ38302347-66B503A5-2DB3-4D02-9F73-B6AD08D4EAF5Q38308357-C703FBA1-BD81-4786-99C6-4A000BAFB7FDQ38309627-E871D604-E548-4B3B-AB63-6CC9D6AFAE58Q38324414-06FF8B27-8AED-428C-9A71-215D27829731Q38328537-AABD20E1-8534-4313-9612-BE89DE3F8CF6Q38332777-D0672963-936F-49A4-A106-33CCBD6518BEQ38335529-F84E6322-7FA6-4B00-B495-A646CA5BFA41Q38374889-09FDAFA8-4EA9-4FAD-A8BC-AB516694AE5DQ38437211-D306A5A3-563F-4678-96AA-C2A9072AE245
P2860
Assembling OX40 aptamers on a molecular scaffold to create a receptor-activating aptamer.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Assembling OX40 aptamers on a molecular scaffold to create a receptor-activating aptamer.
@en
type
label
Assembling OX40 aptamers on a molecular scaffold to create a receptor-activating aptamer.
@en
prefLabel
Assembling OX40 aptamers on a molecular scaffold to create a receptor-activating aptamer.
@en
P2093
P2860
P1476
Assembling OX40 aptamers on a molecular scaffold to create a receptor-activating aptamer.
@en
P2093
Bruce A Sullenger
Claudia M Dollins
David Boczkowski
Eli Gilboa
Jaewoo Lee
Juliana M Layzer
Smita Nair
P2860
P304
P356
10.1016/J.CHEMBIOL.2008.05.016
P577
2008-07-01T00:00:00Z